Blue Wolf Capital Partners, a US-based private equity firm, has agreed to acquire seven Recipharm sites from EQT Private Equity, subject to regulatory approval in a deal that should close in Q4. These are located at Solna, Strängnäs, Höganäs, Karlskoga and Uppsala in Sweden; Pessac, France; and Parets, Spain.

Two recent acquisitions that are both largely focused in the personal care arena were both completed almost simultaneously. Solvay completed the sale of its amphoteric surfactant business to OpenGate Capital, while Ashland finalised that of the personal care business of Schülke & Mayr from investment firm EQT.

Air Liquide has entered into exclusive negotiations with EQT, a differentiated global investment firm with over €62 billion in raise capital, for the sale of its Schülke & Mayr subsidiary. The company had announced its intention to sell Schülke & Mayr in November 2019 as part of a strategy of focusing on its core gases and healthcare businesses.